News Release: July 16, 2025 

Hyaluronic Acid Price, Production, Latest News and Developments in 2025 

The hyaluronic acid market has witnessed substantial shifts in pricing, production capacity, and global trade dynamics over the last few years. As demand has continued to grow from medical, cosmetic, and pharmaceutical applications, countries have responded by boosting production and streamlining exports. This article explores the hyaluronic acid price trend, quarterly price movements, global trade dynamics, and the latest hyaluronic acid news across 2025. For detailed analysis and regular updates on Hyaluronic acid price trend and production News. 

Hyaluronic Acid Price Trend in Past Five Years and Factors Impacting Price Movements 

Over the past five years, hyaluronic acid prices have shown notable volatility, shaped by several key factors including raw material availability, production innovations, regional demand shifts, and global trade conditions. 

In 2020, global average hyaluronic acid prices were around $18,200/MT. That year was heavily impacted by pandemic-related disruptions in manufacturing, leading to limited supply. As demand remained steady, especially in the pharmaceutical and cosmetic industries, prices surged and reached nearly $21,000/MT by Q4 2020. 

Moving into 2021, manufacturers resumed operations and ramped up capacity, particularly in China, South Korea, and parts of Europe. As a result, prices stabilized to an average of $19,500/MT throughout the year. However, raw material supply issues continued to place upward pressure on production costs, and those costs were passed down the supply chain. 

2022 brought new challenges. Increased energy costs and stricter environmental regulations in China caused temporary closures of some mid-sized manufacturing plants. The average hyaluronic acid price during 2022 was about $20,800/MT, with the highest point being $21,400/MT in Q3 2022. At the same time, demand for injectable-grade hyaluronic acid saw a rise, contributing to pricing pressure. 

By 2023, improved fermentation technologies began to influence production efficiencies positively. Manufacturers in the US and Europe began to adopt optimized microbial fermentation processes, reducing the dependency on animal-based production. The shift also improved the overall supply scenario. Prices during 2023 averaged $19,200/MT, marking the first major drop since 2020. However, this price decline was short-lived due to an unexpected spike in demand from dermatology and orthopedics segments, especially in Asia-Pacific markets. 

In 2024, the market entered a phase of relative stabilization. The increased number of producers in India, Brazil, and Southeast Asia helped diversify the global supply chain. Average hyaluronic acid prices ranged between $18,700/MT and $19,400/MT throughout the year. Technological advancements, such as continuous fermentation processes and enhanced purification systems, contributed to cost reduction in some regions, although high logistics costs kept the global price levels from dropping further. 

Now in 2025, prices are showing an upward tick again, with Q1 and Q2 figures indicating a return to around $20,300/MT on average. This is driven by inflationary pressures, tight inventory levels in North America, and sustained high demand from cosmetic manufacturers. The medical segment, particularly in orthobiologics, continues to push global demand. 

Major factors contributing to hyaluronic acid price movements over the past five years include: 

  • Shifting production hubs and supply chain strategies 
  • Adoption of new fermentation and purification technologies 
  • Energy price volatility, especially in production-intensive regions 
  • Regulatory changes and stricter environmental policies 
  • Demand surges in cosmetics, injectables, and pharmaceutical sectors 

Overall, the hyaluronic acid price trend from 2020 to 2025 reflects a dynamic market, sensitive to both macroeconomic shifts and industry-specific innovations. 

Hyaluronic Acid Price Trend Quarterly Update in $/MT: (Estimated Quarterly Prices) 

Here’s an estimated quarterly price update for hyaluronic acid in 2025: 

  • Q1 2025: $20,200/MT 
  • Q2 2025: $20,400/MT 
  • Q3 2025 (estimated): $20,600/MT 
  • Q4 2025 (projected): $20,800/MT 

These quarterly updates show a consistent upward trend, primarily influenced by increased raw material prices, elevated logistics costs, and continued global demand growth. 

Global Hyaluronic Acid Import-Export Business Overview 

The global trade in hyaluronic acid has expanded significantly over the past decade. With rising demand across cosmetic, medical, and wellness industries, several countries have emerged as leading exporters and importers. 

China remains the world’s largest producer and exporter of hyaluronic acid, accounting for more than 50% of global production. The country has developed an extensive manufacturing infrastructure supported by fermentation-based production methods, which allow cost-efficient large-scale output. In 2025, China exports hyaluronic acid to over 70 countries, with major destinations including the United States, Germany, South Korea, and Japan. 

The United States is one of the largest importers of hyaluronic acid, driven by a strong domestic demand in aesthetic medicine, skincare, and orthopedic treatments. Despite some local production, most of the high-purity grades are still sourced from Asian suppliers. The US market is also influenced by regulatory requirements from the FDA, which has created demand for highly standardized and certified imports. 

Europe represents another significant hyaluronic acid importing region. Germany, France, and Italy are among the top importers, primarily using the acid in medical and cosmetic formulations. European markets are characterized by stringent quality standards and a preference for non-animal, fermentation-derived products. As a result, companies in South Korea and Japan, known for their high-quality production, have found consistent export demand in Europe. 

South Korea and Japan are not only major consumers but also key exporters. These countries have invested in advanced R&D and offer high-end cosmetic-grade hyaluronic acid products that meet global quality expectations. In 2025, South Korea’s exports to Southeast Asia and Middle Eastern countries are on the rise, indicating new market expansion trends. 

India and Brazil have begun to emerge as significant players in the production landscape. While still developing full-scale export capabilities, both nations have increased their hyaluronic acid production capacities, primarily to cater to local demand. Brazil’s rising demand in cosmetic dermatology and India’s growing pharmaceutical industry are expected to further increase both domestic use and export volume by 2026. 

The international trade of hyaluronic acid is also affected by logistical factors. Rising container costs and shipment delays, particularly in late 2023 and early 2024, impacted the flow of goods. However, in 2025, most global ports have normalized operations, and shipping constraints have eased. 

Trade policy and tariffs also play a role. For instance, trade tensions between major economies such as the US and China have led some companies to diversify sourcing, seeking alternative suppliers in Southeast Asia or Latin America. This trend is likely to continue as buyers look to reduce risk in their supply chains. 

Hyaluronic acid sales volume globally has been increasing year over year. In 2020, total sales volume was estimated at 4,500 MT. This grew to 6,200 MT by 2023, and in 2025, it is projected to exceed 7,000 MT. The expansion in sales volume is largely attributed to the medical sector’s growing reliance on hyaluronic acid for viscosupplementation in osteoarthritis treatment, dermal fillers, and surgical aids. 

Product diversification is another key driver. Hyaluronic acid is now being used in eye drops, wound healing formulations, dietary supplements, and even tissue engineering. Each new application opens doors for international trade and pushes both production and import-export numbers upward. 

Overall, the global hyaluronic acid import-export business is expected to continue expanding. As more countries develop internal capabilities and refine regulatory pathways, the market will likely become more competitive, and price stabilization is expected post-2026. However, in 2025, pricing remains sensitive to demand surges, shipping routes, and global trade policies. 

To access the latest hyaluronic acid price news, hyaluronic acid production updates, and market forecasts, request a sample from https://datavagyanik.com/reports/hyaluronic-acid-market/ 

Hyaluronic Acid Production Trends by Geography 

Hyaluronic acid production has undergone significant transformation in recent years, both in terms of geographic spread and technological sophistication. In 2025, the global production landscape is characterized by both traditional strongholds and emerging players. The following is an overview of key regions shaping the hyaluronic acid production market: 

China 

China remains the dominant global producer of hyaluronic acid. The country holds a strong manufacturing base supported by high-volume fermentation facilities and a well-developed raw material supply chain. Chinese companies focus largely on industrial-scale production, supplying both low and high molecular weight grades for use in cosmetics, pharmaceuticals, and medical devices. Due to cost-effective operations and favorable export infrastructure, China exports to over 70 countries. In 2025, production is also expanding in inland provinces to tap into local labor and reduce coastal dependency. 

South Korea 

South Korea is a leading producer of premium-grade hyaluronic acid, especially for cosmetic and skincare applications. Korean manufacturers prioritize purity, consistency, and advanced molecular tailoring, making their products particularly suitable for high-end dermal fillers and anti-aging formulations. Government support for biotech innovation has further boosted research in fermentation techniques and product safety. In 2025, South Korea continues to invest in scaling production with a focus on export-led growth to Southeast Asia and Europe. 

Japan 

Japan, though smaller in volume compared to China, plays a significant role in the production of pharmaceutical and medical-grade hyaluronic acid. Japanese firms emphasize high standards of quality and focus on niche applications such as ophthalmic solutions, joint injections, and wound care. Japanese producers are also known for integrating advanced purification technologies to meet global regulatory requirements. In 2025, Japanese companies are collaborating with international pharmaceutical brands to co-develop specialized hyaluronic acid-based formulations. 

United States 

The US has seen a rise in domestic production of hyaluronic acid, primarily driven by the growth of the aesthetic medicine market. Several biotech companies have invested in fermentation-based production, supported by strict quality assurance and FDA-regulated facilities. The focus is primarily on injectable-grade and cosmetic formulations. Despite this growth, the US still imports a large share of its supply from Asia, especially for industrial-grade use. In 2025, more startups are entering the production landscape, aiming to localize supply chains and reduce import dependency. 

Germany and France 

Western Europe, particularly Germany and France, has well-established hyaluronic acid production facilities focused on the pharmaceutical and medical sectors. These countries follow rigorous EU regulations and concentrate on cleanroom manufacturing, especially for orthopedic and surgical applications. France is also becoming a hub for cosmetic-grade production with strong links to global skincare brands. In 2025, European companies are adopting continuous production techniques to reduce operational costs and carbon emissions. 

India 

India is an emerging player in hyaluronic acid production. Several pharmaceutical companies have started producing both low and medium molecular weight hyaluronic acid using microbial fermentation. The domestic demand is growing rapidly due to the expansion of the aesthetic, orthopedic, and pharmaceutical sectors. In 2025, India is expected to not only meet a majority of its internal needs but also become a low-cost supplier to Southeast Asia and Africa. Government incentives for biopharmaceutical manufacturing are expected to further boost capacity. 

Brazil 

In South America, Brazil is becoming a regional production hub for hyaluronic acid, mainly for cosmetic and dermatology use. The country’s aesthetic market is expanding rapidly, and local producers are working to match international quality standards. Brazil’s growing biopharma sector is exploring additional applications such as eye drops, supplements, and wound care. In 2025, Brazil is expected to increase production for both domestic consumption and export to neighboring countries. 

Southeast Asia 

Countries like Thailand, Malaysia, and Vietnam are beginning to invest in hyaluronic acid production, driven by lower labor costs and growing domestic demand. While these countries are still in the early stages, they are focusing on fermentation-based technologies and contract manufacturing for global brands. These regions are also exploring partnerships with Korean and Chinese firms to leverage technical expertise. 

Overall, the geographic trends in hyaluronic acid production in 2025 reflect a shift toward localized, high-quality, and sustainable manufacturing. The expansion into new regions is also expected to reduce dependency on a few large producers and create a more balanced global supply chain. 

Hyaluronic Acid Market Segmentation 

The hyaluronic acid market is segmented across several key parameters that define its use, grade, form, and end-user industry. The following are the main segments: 

1. By Application 

  • Cosmetic (Topical formulations, dermal fillers) 
  • Medical (Ophthalmology, orthopedics, wound healing) 
  • Pharmaceutical (Drug delivery, supplements) 
  • Food and Nutraceuticals 

2. By Molecular Weight 

  • Low Molecular Weight 
  • Medium Molecular Weight 
  • High Molecular Weight 

3. By Form 

  • Powder 
  • Gel 
  • Solution 

4. By End-User 

  • Aesthetic Clinics 
  • Hospitals 
  • Pharmaceutical Companies 
  • Dermatology Centers 
  • Contract Manufacturers 

5. By Region 

  • North America 
  • Europe 
  • Asia Pacific 
  • Latin America 
  • Middle East & Africa 

Explanation of Leading Segments: 

Application-Based Segmentation 

The cosmetic application segment leads the hyaluronic acid market globally. Topical skincare formulations such as anti-aging serums, moisturizers, and sheet masks use low molecular weight hyaluronic acid for deep hydration and elasticity enhancement. The growing popularity of non-invasive aesthetic treatments, especially dermal fillers, is driving this segment further. In 2025, more than 45 percent of total hyaluronic acid sales volume is attributed to the cosmetic industry. 

Medical applications form the second-largest segment, especially in orthopedic and ophthalmic treatments. Hyaluronic acid is widely used in viscosupplementation injections for osteoarthritis, cataract surgery lubricants, and eye-drop formulations for dry eye disease. With the aging population increasing, the demand for these applications is steadily rising. Hospitals and specialty clinics remain the main users of medical-grade hyaluronic acid. 

Pharmaceutical and nutraceutical applications are emerging segments. Oral hyaluronic acid is now included in joint health supplements, beauty-from-within products, and digestive aids. This segment is growing rapidly, especially in markets like Japan, the US, and South Korea where consumers are familiar with ingestible skincare. 

Molecular Weight-Based Segmentation 

Low molecular weight hyaluronic acid dominates due to its superior skin penetration capabilities. It is widely used in serums, eye creams, and cosmetic injectables. This type is also favored in certain oral supplements for its better absorption in the gut. 

High molecular weight hyaluronic acid, on the other hand, is extensively used in ophthalmology and orthopedics. Its longer retention time in joints and the eye makes it suitable for therapeutic applications. In 2025, more innovations are expected in developing hybrid molecular weight products for extended release and improved therapeutic action. 

Form-Based Segmentation 

Powdered hyaluronic acid is the most common form, especially for bulk sales to manufacturers. It is easy to transport, store, and formulate into various products. Gel forms are primarily used in injectables and medical devices. Solutions are used in ophthalmic products and topical sprays. 

In 2025, ready-to-use formulations are gaining popularity in clinics and hospitals, reducing the need for reconstitution and manual mixing. This is expected to increase the market share of gel and solution forms. 

End-User Segmentation 

Aesthetic clinics represent a major share of the market, particularly in countries with high per capita expenditure on beauty and personal care. The growing demand for minimally invasive cosmetic procedures like fillers and skin boosters supports this segment’s growth. 

Hospitals and pharmaceutical companies are leading consumers in the medical application segment. Dermatology centers and contract manufacturers play a vital role in customizing and supplying products to brand owners. In 2025, private-label formulations for skincare and medical use are seeing higher demand, especially from emerging markets. 

Regional Segmentation 

Asia Pacific remains the largest regional market, led by China, South Korea, and Japan. This region is not only a manufacturing hub but also a major consumer market. North America follows closely due to its advanced aesthetic industry and high healthcare spending. 

Europe has a balanced demand across cosmetic and medical segments, with strong regulations ensuring product safety. Latin America and the Middle East are seeing faster growth rates due to increasing awareness and rising disposable income. 

In conclusion, the hyaluronic acid market is multi-dimensional, with each segment contributing uniquely to overall growth. Leading segments such as cosmetics and orthopedics continue to dominate, while pharmaceuticals and nutraceuticals are growing steadily. With ongoing product innovation and geographic expansion, market segmentation will continue to evolve over the next several years.